Conn. Gen. Stat. § 4a-53b: Bulk purchases of prescription drugs by state agencies and the Judicial Branch. Negotiation. Compact with other states. Reporting.

(a) As used in this section and sections 4a-53c and 4a-53d, “drug purchasing agency” means the Judicial Branch and the Department of Mental Health and Addiction Services, Children and Families, Developmental Services or Public Health. Except as provided in subsection (c) of this section, the Department of Administrative Services shall negotiate bulk prices for prescription drugs on behalf of drug purchasing agencies with the goal of purchasing such drugs at lower prices than the prices of such drugs purchased by a single drug purchasing agency.

(b) In purchasing drugs at bulk prices pursuant to this section, a drug purchasing agency may enter into a compact with officials in other states to increase the state's purchasing power in negotiations with pharmaceutical companies.

(c) A drug purchasing agency may negotiate its own drug prices upon demonstrating to the Commissioner of Administrative Services that it is able to purchase such drugs at a cheaper price than the state's bulk pricing agreements, or if operational conditions require. Such demonstration shall be made in writing.

(d) Not later than February 1, 2026, the Commissioner of Administrative Services, or the commissioner's designee, shall file a report, in accordance with the provisions of section 11-4a, with the joint standing committees of the General Assembly having cognizance of matters relating to appropriations and the budgets of state agencies, general law, human services and public health on any savings realized from bulk purchases of prescription drugs pursuant to subsection (a) of this section.